SCHEMBL387010

SCHEMBL387010

O=CC1CC[CH]CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL385719 0.85 — —
SCHEMBL2878395 0.84 — —
SCHEMBL3392956 0.81 — —
SCHEMBL887222 0.75 ADH1A (0.32) —
SCHEMBL887195 0.75 ADH1A (0.32) —
SCHEMBL823159 0.75 ADH1A (0.32) —
SCHEMBL4848 0.75 — —
SCHEMBL1230432 0.73 ALDH1A1 (0.39) —
SCHEMBL1230434 0.73 ALDH1A1 (0.39) —
SCHEMBL6347535 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113214342-A 23-hydroxy betulinic acid 3-site modified derivative, preparation method and application 中国药科大学 2021-08-06 — — CN claimed
CN-101253148-B Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use XENOPORT INC 2013-01-02 — — CN claimed
CN-101253148-A Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use XENOPORT INC (US) 2008-08-27 — — CN claimed
CN-113214342-B 23-hydroxy betulinic acid 3-site modified derivative, preparation method and application 中国药科大学 2022-05-24 — — CN disclosed
CN-114206872-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR8 agonists 百济神州有限公司 2022-03-18 — — CN disclosed
CN-113214342-A 23-hydroxy betulinic acid 3-site modified derivative, preparation method and application 中国药科大学 2021-08-06 — — CN disclosed
CN-112513043-A Broad spectrum carbapenems 维纳拓尔斯制药公司 2021-03-16 — — CN disclosed
CN-112321590-A Imidazo [2,1-F ] [1,2,4] triazin-4-amine derivatives as TLR8 agonists 百济神州有限公司 2021-02-05 — — CN disclosed
CN-107501380-B 23-hydroxy betulinic acid 23-position modified derivative, preparation method and application thereof 中国药科大学 2020-09-29 — — CN disclosed
CN-107429059-A ENERGY-SENSITIVE RESIN COMPOSITION 东京应化工业株式会社 2017-12-01 — — CN disclosed
CN-106575080-A Energy-sensitive resin composition 东京应化工业株式会社 2017-04-19 — — CN disclosed
US-20040132784-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2004-07-08 — — US disclosed
EP-1434782-A2 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF University of Virginia Patent Foundation (US) 2004-07-07 — — EP disclosed
US-6723745-B2 PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASE IN WARM BLOODED ANIMAL SANKYO COMPANY, LIMITED (JP) 2004-04-20 — — US disclosed
US-20030236297-A1 Amino alcohol derivatives SANKYO COMPANY, LIMITED (JP) 2003-12-25 — — US disclosed
WO-2003086408-A1 USE OF A2A ADENOSINE RECEPTOR AGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-10-23 — — WO disclosed
US-20030186926-A1 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-10-02 — — US disclosed
WO-2003029264-A2 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2003-04-10 — — WO disclosed
EP-1300405-A1 AMINO ALCOHOL DERIVATIVES Sankyo Company, Limited (JP) 2003-04-09 — — EP disclosed
US-4898455-A Pyridine liquid crystalline compounds HOFFMANN-LA ROCHE INC. (US) 1990-02-06 — — US disclosed
Send feedback